On March 1, the U.S. Food and Drug Administration (FDA) approved Odactra, the first allergen extract to be administered sublingually to treat house dust…
On Feb. 28, the U.S. Food and Drug Administration (FDA) approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment…
Consuming certain probiotics helps improve quality of life in seasonal allergy sufferers, according to a study in the American Journal of Clinical Nutrition. Read…
On Feb. 15, the U.S. Food and Drug Administration announced that Zimmer Biomet has recalled its Biomet Comprehensive Reverse Shoulder Humeral system because of…
According to a study in the Journal of the Infectious Diseases Society, the incidence of multidrug-resistant Gram-negative enteric Enterobacteriaceae in children increased during 2007-2015…
On Feb. 15, the U.S. Food and Drug Administration (FDA) approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Read more
Since the Magnet® Vision was published in 2008, it has inspired actions by nurses at Lehigh Valley Hospital (LVH), a Magnet-recognized academic community hospital…
On Feb. 28, the U.S. Food and Drug Administration (FDA) approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for…
According to a study in the Journal of the Infectious Diseases Society, the incidence of multidrug-resistant Gram-negative enteric Enterobacteriaceae in children increased…
On Feb. 15, the U.S. Food and Drug Administration (FDA) approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Read more